AKT1 and breast cancer: This evidence highlights the oncogenic role of KAT7 in enhancing breast cancer radioresistance through transcriptional upregulation of PIK3CA and PI3K/AKT pathway activation, suggesting therapeutic potential in KAT7 inhibition.